A Novel Human in Vitro Papillomavirus Type 16 Positive Tonsil Cancer Cell Line With High Sensitivity to Radiation and Cisplatin

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5469-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CD133 Antisense Suppresses Cancer Cell Growth and Increases Sensitivity to Cisplatin in Vitro

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Target Cell Cyclophilins Facilitate Human Papillomavirus Type 16 Infection

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2009English

Antibodies Against Human Papillomavirus Type 16 (HPV-16) and Conjunctival Squamous Cell Neoplasia in Uganda

British Journal of Cancer
Cancer ResearchOncology
2003English

PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

SOX17 Increases the Cisplatin Sensitivity of an Endometrial Cancer Cell Line

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Association of ATP7A Expression and in Vitro Sensitivity to Cisplatin in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Human Papillomavirus Type 16 Infection and Local Lymph Node Metastasis in Patients With Squamous Cell Carcinoma

Journal of Hard Tissue Biology
Sports MedicineCell BiologyBiochemistryOrthopedicsBiomaterialsDentistryMedicine
2016English

Novel Triple‑positive Markers Identified in Human Non‑small Cell Lung Cancer Cell Line With Chemotherapy-Resistant and Putative Cancer Stem Cell Characteristics

Oncology Reports
MedicineCancer ResearchOncology
2018English

Correction To: Human Papillomavirus Type 16 Causes a Defined Subset of Conjunctival in Situ Squamous Cell Carcinomas

Modern Pathology
Forensic MedicinePathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy